Top Markets
Coin of the day
Clinical Laserthermia Systems AB (publ) Clinical Laserthermia Systems AB (publ)

Clinical Laserthermia Systems AB (publ)

CLS-B
Pozycja w akcjach #16822
Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased... Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Cena akcji
$0.51099792
Kapitalizacja rynkowa
$13.22M
Zmiana (1 dzień)
-0.54%
Zmiana (1 rok)
99.27%
Kraj
SE
Handel Clinical Laserthermia Systems AB (publ) (CLS-B)

Kategoria

Zyski dla Clinical Laserthermia Systems AB (publ) (CLS-B)
Zyski w Dec 2025 TTM: $-4.56M
Według najnowszych raportów finansowych Clinical Laserthermia Systems AB (publ), obecny zysk firmy wynosi $-4.56M. W roku 2023 firma osiągnęła zysk w wysokości $-8.02M, spadek w porównaniu do zysku z roku 2022, który wynosił $-6.83M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Clinical Laserthermia Systems AB (publ) od 2008 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $-4.56M 5.01%
2024 $-4.34M -45.87%
2023 $-8.02M 17.30%
2022 $-6.83M -3.57%
2021 $-7.09M 1.09%
2020 $-7.01M 50.89%
2019 $-4.65M 26.33%
2018 $-3.68M 41.43%
2017 $-2.60M -12.33%
2016 $-2.97M 50.76%
2015 $-1.97M -13.93%
2014 $-2.29M -19.66%
2013 $-2.85M 45.81%
2012 $-1.95M 92.67%
2011 $-1.01M 36.66%
2010 $-741.13K 167.52%
2009 $-277.04K 223.62%
2008 $-85.61K 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$8.47B -185,887.29%
US
$4.51B -99,160.22%
US
$5.56B -122,210.54%
IE
$5.56B -122,180.64%
IE
$3.39B -74,384.19%
US